NCT05796713

Brief Summary

Patient with childhood hydrocephalus (HC) tend to present late in Low medium income countries (LMICs). This project will study the barriers leading to patients' and health system delay in patients with childhood HC. This will be done via a quantitative and qualitative study analysis. The data will be collected prospectively.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2023

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

March 7, 2023

Completed
27 days until next milestone

First Posted

Study publicly available on registry

April 3, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 27, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 27, 2024

Completed
Last Updated

December 15, 2025

Status Verified

December 1, 2025

Enrollment Period

11 months

First QC Date

March 7, 2023

Last Update Submit

December 7, 2025

Conditions

Hydrocephalus in Children

Outcome Measures

Primary Outcomes (3)

  • Patient Presentation time in days

    Time in days, from the onset of symptoms to the time the patient seeks medical advice.

    14 days

  • Diagnostic delay in days

    Time in days between the patient's presentation and the confirmation of the diagnosis, in days

    14 days

  • Treatment delay in days

    The duration (in days) between the diagnosis and initiation of treatment

    14 days

Secondary Outcomes (3)

  • Treatment outcome as perceived by parents/caregivers

    4 weeks

  • Parents/caregivers satisfaction

    4 weeks

  • Reason for delay in presentation, diagnosis and treatment

    4 weeks

Interventions

HydrocephalusOTHER

Interview

Eligibility Criteria

AgeUp to 5 Years
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Patients who present at the Lagos State University Teaching Hospital, Ikeja, Lagos for management of hydrocephalus

You may qualify if:

  • All patients less than 5 years of age with HC confirmed with either magnetic resonance or computerized tomographic images
  • Hospital staff members, who have been working within the Neurosurgical unit for at least 5 years.

You may not qualify if:

  • All patents not investigated or operated at our centre
  • Patients older than 5 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lagos State University Teaching Hospital

Ikeja, Lagos, 20001, Nigeria

Location

Study Officials

  • Olufemi Idowu, FWACS, FACS

    Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 7, 2023

First Posted

April 3, 2023

Study Start

March 1, 2023

Primary Completion

January 27, 2024

Study Completion

January 27, 2024

Last Updated

December 15, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

Anonymized data on request

Shared Documents
STUDY PROTOCOL
Time Frame
Jan 2024 till Jan 2025
Access Criteria
via email

Locations

NG(1)